StockNasdaqGSIDXX

Idexx Laboratories

$513.39
+0.00 (+0.00%)today

Valuation & earnings

P/E ratio
36.03
Forward P/E
30.67
EPS (ttm)
$14.25
Forward EPS
$16.74
Price/book
25.11
PEG ratio
2.86
Payout ratio
0%

Financials (ttm)

Revenue (ttm)
4.6B
Revenue growth
9.7%
Profit margin
25.03%
Return on equity
74.21%
Total cash
196.9M
Total debt
1.1B

Earnings (EPS)

QuarterEstimateActualSurprise
Sep 30, 20253.153.4+8.08%
Dec 31, 20252.943.08+4.81%
Mar 31, 20263.413.47+1.74%
Jun 30, 20263.934.27+8.54%

Next earnings date: Nov 2, 2026

Analyst view

Consensus ratingBuy14 analysts
Strong buy 4Buy 4Hold 5Strong sell 1
12-month price targetsImplied upside: +36.14%
470
698.92
805
LowCurrent priceHigh

Latest news

(English)

Related products

How visible is Idexx Laboratories in AI search?

We ask AI search engines about Idexx Laboratories and its market — live — and measure whether and how prominently the brand appears in their answers.

No AI visibility check has been run for Idexx Laboratories yet.

Run a live check to see how AI search engines talk about this brand right now.

Is your brand this visible in AI search?

Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.